Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.
Escherichia coli hemolysin (Hly) was isolated from bacterial culture supernatants by polyethylene glycol precipitation and centrifugation in glycerol density gradients. The toxin preparations contained less than 1 mol of lipopolysaccharide per 10 mol of protein, and they had no fatty acids. The capacity of purified hemolysin to stimulate superoxide anion production in polymorphonuclear leukocytes was monitored kinetically in a lumimeter by using the lucigenin assay and was correlated with the kinetics of transmembrane pore formation. When applied to leukocytes suspended in protein-free buffer, very low concentrations (0.02 to 0.1 HU/ml) of the toxin strongly stimulated the production of superoxide anions; shortly thereafter, irreversible membrane permeabilization occurred. When the toxin was applied at concentrations exceeding 0.2 to 0.3 HU/ml, membrane permeabilization was so rapid that the cells were unable to mount a respiratory burst. When applied in the narrow range of 0.05 to 0.1 HU/ml, E. coli hemolysin rivaled phorbol myristate acetate in its capacity to stimulate production of superoxide anions. Additionally, hemolysin applied at doses that elicited no pore formation (0.01 to 0.02 HU/ml) primed leukocytes for an augmented response to subsequent challenge by the phorbol ester. These data demonstrate that very low doses of E. coli hemolysin can evoke cellular reactions that appear independent of and precede transmembrane pore formation and cell death.
Bhakdi
S
S
Institute of Medical Microbiology, University of Mainz, Hochhaus Augustusplatz, Federal Republic of Germany.
Martin
E
E
D001426:Bacterial Proteins / Q000494:pharmacology*; D001427:Bacterial Toxins / Q000494:pharmacology*; D002463:Cell Membrane Permeability; D004926:Escherichia coli; D029968:Escherichia coli Proteins; D005434:Flow Cytometry; D006460:Hemolysin Proteins / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D011419:Propidium / Q000494:pharmacology; D013481:Superoxides / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D001426:Bacterial Proteins; D001427:Bacterial Toxins; D029968:Escherichia coli Proteins; D006460:Hemolysin Proteins; C036507:Hlya protein, E coli; D013481:Superoxides; D011419:Propidium; D013755:Tetradecanoylphorbol Acetate